Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril
Completed · Not applicable
Conditions studied: Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design, Hypertension
In brief
The purpose of this trial is to evaluate if an objective clinical decision of anti-hypertensive therapy can be made using an N-of-1 (single patient) trial design.
Key facts
- Study ID
- NCT01258764
- Run by
- Scripps Translational Science Institute
- People needed
- 2
- Starts
- 2010-11-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2015-05-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Grade 1 Hypertension
- Treatment naïve
- GFR > 60 within previous 3 months
- Urinary microalbumin level normal during previous 3 months
You may not qualify if…
- Pregnancy (Fetal morbidity and mortality may occur with the use of ACE inhibitors.)
- Uncontrolled Hyperthyroidism
- Sleep Apnea
- Primary Aldosteronism
- Renovascular Disease
- Cushing's Syndrome or steroid therapy
- No evidence of end organ damage
- EKG with evidence of LVH within previous 3 months
- Collagen Vascular Disease
- Current Smoker
Where it is running
- Scripps Clinic — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.